CG ONCOLOGY INC
CGONNASDAQ🏆 #968 by market capEarnings Nov 12US Equity
$73.84▲ $3.74 (+5.07%)
Simulated price1h—
24h▲ 5.1%
7d—
14d—
30d—
1y—
🏦Market Cap
$6.79B
Small Cap
📈Revenue Growth (YoY)
+254.7%
High Growth
📊Gross Margin
-82.7%
Thin
💵FCF Margin
-2879.6%
Thin
⚖️P/S Ratio
1090.9x
Expensive
Otter Score
60
Fair
📊
Analyst Ratings
Price
$73.84
Total
10
Raised
1
Lowered
0
Avg PT
$87.20
H / L
$100 / $80
| Institution | Action | Rating | Date |
|---|---|---|---|
HC Wainwright & Co. | Reiterated | Buy | 2026-05-18 |
Truist Securities | Reiterated | Buy | 2026-05-14 |
RBC Capital | Reiterated | Outperform | 2026-05-11 |
JP Morgan | Reiterated | Overweight | 2026-05-11 |
Wedbush | Reiterated | Outperform | 2026-05-11 |
Piper Sandler | Reiterated | Overweight | 2026-01-16 |
Morgan Stanley | Reiterated | Overweight | 2025-09-17 |
Cantor Fitzgerald | Reiterated | Overweight | 2025-09-08 |
B of A Securities | Reiterated | Buy | 2024-10-08 |
Goldman Sachs | Upgraded | Neutral → Buy | 2024-05-14 |
One row per institution, most recent rating